Janus Henderson Group PLC Raises Stock Position in CME Group Inc. $CME

Janus Henderson Group PLC boosted its position in shares of CME Group Inc. (NASDAQ:CME) by 13.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 2,048,415 shares of the financial services provider’s stock after purchasing an additional 236,213 shares during the period. Janus Henderson Group PLC’s holdings in CME Group were worth $559,389,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in CME Group by 1.7% in the 4th quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock worth $9,802,366,000 after buying an additional 588,509 shares in the last quarter. State Street Corp grew its stake in CME Group by 0.4% in the 4th quarter. State Street Corp now owns 16,144,525 shares of the financial services provider’s stock worth $4,408,747,000 after buying an additional 56,725 shares in the last quarter. Norges Bank purchased a new position in CME Group in the 4th quarter worth approximately $1,523,241,000. Bank of New York Mellon Corp grew its stake in CME Group by 2.8% in the 4th quarter. Bank of New York Mellon Corp now owns 4,924,475 shares of the financial services provider’s stock worth $1,344,776,000 after buying an additional 134,242 shares in the last quarter. Finally, Ameriprise Financial Inc. grew its stake in CME Group by 2.8% in the 3rd quarter. Ameriprise Financial Inc. now owns 4,812,914 shares of the financial services provider’s stock worth $1,300,450,000 after buying an additional 130,848 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on CME shares. Morgan Stanley cut their price objective on shares of CME Group from $362.00 to $353.00 and set an “overweight” rating for the company in a research note on Thursday, April 23rd. Raymond James Financial upped their price objective on shares of CME Group from $310.00 to $320.00 and gave the stock an “outperform” rating in a report on Monday, April 6th. Barclays reduced their target price on shares of CME Group from $343.00 to $316.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 23rd. Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and upped their target price for the stock from $316.00 to $323.00 in a research report on Thursday, June 11th. Finally, Argus reaffirmed a “hold” rating on shares of CME Group in a research report on Wednesday, March 4th. Eleven analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $305.18.

CME Group Stock Performance

Shares of NASDAQ CME opened at $252.54 on Thursday. The firm’s 50-day moving average price is $282.02 and its 200-day moving average price is $287.75. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a market cap of $91.51 billion, a PE ratio of 21.55, a PEG ratio of 2.92 and a beta of 0.21. CME Group Inc. has a 52-week low of $244.56 and a 52-week high of $329.16.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. The firm had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter last year, the firm posted $2.80 EPS. As a group, analysts anticipate that CME Group Inc. will post 12.28 EPS for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be issued a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Tuesday, June 9th. CME Group’s dividend payout ratio (DPR) is presently 44.37%.

Insider Transactions at CME Group

In other news, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the transaction, the insider owned 27,702 shares in the company, valued at $8,438,860.26. This represents a 17.20% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the transaction, the chief executive officer owned 55,630 shares in the company, valued at $16,606,111.30. This trade represents a 38.62% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 0.30% of the company’s stock.

Key CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME announced a planned leadership transition that appears orderly: longtime CEO Terry Duffy will move to executive chairman in March 2027, while President and CFO Lynne Fitzpatrick will become CEO. Investors may view the succession plan as reducing near-term key-person risk. Article Title
• Neutral Sentiment: Management’s transition also signals continuity, since Fitzpatrick already serves as president and CFO and has been part of CME’s leadership team. That makes the handoff less disruptive than an outside hire. Article Title
• Negative Sentiment: Duffy said CME plans to sue the CFTC over perpetual futures, highlighting a more confrontational regulatory backdrop. The dispute could add legal uncertainty and revive investor concerns about competition from new crypto derivatives products. Article Title
• Negative Sentiment: Kraken’s launch of perpetual futures for U.S. traders through a CFTC-regulated venue adds to fears that competitors could chip away at CME’s crypto derivatives franchise over time. Article Title

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.